Phase 1 Ischemia Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
Ischemia Reperfusion InjuryDelayed Graft Function
Rhode Island Hospital20 enrolled1 locationNCT04005469
Recruiting
Phase 1
Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
Delayed Cerebral IschemiaAneurysmal Subarachnoid Hemorrhage
University of Florida30 enrolled1 locationNCT06863480
Recruiting
Phase 1
Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
Myocardial Ischemia
University of Virginia40 enrolled1 locationNCT05762952
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
Myocardial IschemiaCoronary Artery Disease
GE Healthcare54 enrolled5 locationsNCT04604782
Recruiting
Phase 1
Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia
Critical Limb Ischemia
Allife Medical Science and Technology Co., Ltd.27 enrolled1 locationNCT06359912